Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Fong-Fu Chou
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=4.104
------>paper_class3=2
------>paper_class2=1
------>vol=20
------>confirm_bywho=amel
------>insert_bywho=jhorng
------>Jurnal_Rank=16.0
------>authors4_c=
------>comm_author=1
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=0
------>page2=1350
------>medlineContent=
------>unit=G0100
------>insert_date=20091113
------>iam=4
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=
------>score=500
------>journal_name=HUMAN GENE THERAPY
------>paper_name=Oral Gene Therapy for Hypoparathyroidism: A Rat Model
------>confirm_date=20091113
------>tch_id=082003
------>pmid=19619000
------>page1=1344
------>fullAbstract=Abstract The use of nonionic polymeric micelles orally to protect and deliver plasmid DNA in vivo was investigated. Parathyroid hormone (PTH)(1-34) gene (179 bp) was inserted into a human cytomegalovirus promoter (PCMV) and E. coli competent cells were used to amplify the cDNA. Polymeric micelle formations (100 mul) formed from PCMV-PTH(1-34) cDNA (7.2 mug/mul) and 6% (w/v) polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) was administered at 8-hr intervals for 48 hr and then at 8-hr intervals for 24 hr weekly for 3 weeks. Parathyroidectomized rats receiving 150 mul of EDTA (10 mM) before each dose of formation served as the study group; rats receiving drinking water, EDTA (10 mM), PCMV-PTH(1-34) cDNA and PCMV-PTH(1-34) cDNA plus EDTA at the same amount and time intervals served as the control groups. Serum levels of calcium and PTH(1-34) were measured weekly for 4 weeks. Immunohistochemical stain for PTH(1-34), reverse transcriptase polymerase chain reaction for PTH(1-34) mRNA and the relative density of PTH(1-34) mRNA were performed at 2 and 4 weeks after oral gene therapy in different organs. One third to three of five rats in the control groups died after parathyroidectomy. Serum levels of calcium and PTH(1-34) were higher in the study than in the control groups. In the study group, positive stain of PTH(1-34) and PTH(1-34) mRNA could be found in those organs. Relative densities of PTH(1-34) mRNA were higher in the study than in the drinking water group in different organs. Oral gene therapy can maintain calcium and PTH(1-34) levels in parathyroidectomized rats.
------>tmu_sno=None
------>sno=22955
------>authors2=Shun-Chen Huang
------>authors3=Shwu-Fen Chang
------>authors4=Jiahorng Liaw
------>authors5=Pei-Hua Hung
------>authors6=
------>authors6_c=
------>authors=Fong-Fu Chou
------>delete_flag=0
------>SCI_JNo=67935
------>authors2_c=
------>publish_area=0
------>updateTitle=Oral gene therapy for hypoparathyroidism: a rat model.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2009
------>submit_flag=None
------>publish_month=11
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z